Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop

Celiac disease has been an outlier among intestinal diseases. Although not as prevalent as irritable bowel syndrome, it is significantly more common than inflammatory bowel disease.1 Although patients are rarely hospitalized or undergo surgery due to celiac disease, attributable mortality is increased and burden of treatment, defined as the degree of difficulty in following treatment, is higher than other common luminal diseases.2

This entry was posted in News. Bookmark the permalink.